FGFR-IN-7 structure
|
Common Name | FGFR-IN-7 | ||
|---|---|---|---|---|
| CAS Number | 2488764-17-4 | Molecular Weight | 374.81 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H21ClF2N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FGFR-IN-7FGFR-IN-7 (compound 17) is an orally active, potent and BBB-penetrated FGFR (fibroblast growth factor receptor) modulator. FGFR-IN-7 shows neuroprotective activity. FGFR-IN-7 improves brain exposure and reduced risk of phospholidosis. FGFR-IN-7 can be used for neurodegenerative diseases research[1]. |
| Name | FGFR-IN-7 |
|---|
| Description | FGFR-IN-7 (compound 17) is an orally active, potent and BBB-penetrated FGFR (fibroblast growth factor receptor) modulator. FGFR-IN-7 shows neuroprotective activity. FGFR-IN-7 improves brain exposure and reduced risk of phospholidosis. FGFR-IN-7 can be used for neurodegenerative diseases research[1]. |
|---|---|
| Related Catalog | |
| In Vivo | FGFR-IN-7 (compound 17) (1 mg/kg, Orally, once daily for 10 days) significantly enhances recovery of coordinated movement in the in vivo rat acute stroke model[1]. |
| References |
| Molecular Formula | C16H21ClF2N4O2 |
|---|---|
| Molecular Weight | 374.81 |